Abstract: Exemplary embodiments are provided of antennas and antenna systems including the same. In an exemplary embodiment, an antenna generally includes a radiating patch element having an annular rectangular shape. An antenna ground plane is spaced apart from the radiating patch element. A feeding element electrically coupled to the radiating patch element via proximity coupling. The antenna also includes at least two shorting elements electrically coupling the radiating patch element to the antenna ground plane. In other exemplary embodiments, the antenna systems include at least one active GPS antenna, at least one passive antenna, and an isolator.

Abstract: A vibrating simulation device is configured to test an object. The vibrating simulation device includes a carrying module, a driving module and a pressing module. The carrying module carries the object. The driving module drives the carrying module to vibrate. The press module is located upon the carrying module and presses on the object. The pressing module includes a bag and fillers. The fillers are replaceably filled in the bag.

Abstract: Disclosed are a catalyst and preparation method and use thereof. The catalyst has a constitution represented as the formula below, wherein, D represents at least one element selected from the group consisting of copper, magnesium, manganese, stibium and zinc; E represents at least one element selected from the group consisting of tungsten, silicon, nickel, palladium, ferrum and plumbum; Z is selected from the group consisting of SiC, MoO3, WO3, TiO2 and ZrO2; y/x=11.1-50:100; a=0.1-3; b=0.01-5; c=0.01-5; d=0.01-3; e=0.01-2; f is the proportion of oxygen atom balancing the valence. The method comprises: (i) formulating Solution A with molybdenum, phosphorus, and vanadium compounds; formulating Solution B with dissolve potassium compound and a D-containing compound; formulating Solution C with an E-containing compound; (ii) mix Solutions A, B and C under a temperature of ?5-10° C.

Abstract: A driving system of an electric vehicle and an electric vehicle comprising the same are provided. The driving system comprises: a driving motor, a transmission and a hydraulic system. The transmission may include an input shaft, an output shaft, a first transmission unit, a first clutch, a second transmission unit and a second clutch.

Abstract: A compound of formula: where Ar1, Ar2, X, R3, and m are as disclosed herein or a pharmaceutically acceptable salt thereof (a “Cycloheteroalkenyl Compound”); compositions comprising an effective amount of a Cycloheteroalkenyl Compound; and methods for treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia, or depression in an animal comprising administering to an animal in need thereof an effective amount of a Cycloheteroalkenyl Compound are disclosed herein.

Abstract: According to various aspects, exemplary embodiments are disclosed of ground independent multi-band antenna assemblies. In an exemplary embodiment, a ground independent multi-band antenna assembly is operable within at least a first frequency range and a second frequency range different than the first frequency range. The antenna assembly generally includes an annular ground element, a feed element, a patch element, and a high band element. The feed element includes a feeding point and a shorting point electrically connected to the annular ground element. The patch element is electrically shorted to the annular ground element by the feed element. The high band element is electrically connected to the feed element.

Abstract: The present invention provides a process for regenerating a deactivated heteropolymolybdophosphoric acid catalyst, comprising the steps of grinding the deactivated catalyst into particles having a particle size of 40 mesh or less, mixing the particles with a mixture comprising aqua ammonia, an aqueous solution containing ammonium ions and organic auxiliaries, kneading the same in a kneader to obtain a paste, drying the paste, molding the paste into cylindrical particles with a through hole in its longitudinal axis, and heating the paste in atmosphere at 350˜450° C. for 1˜10 hours to produce the generated catalyst.

Abstract: A method includes determining a location of erroneous content in a web page in response to a user's request for correcting the erroneous content in the web page; receiving the user's input of correction content for the erroneous content; and submitting correction information to a correction service provider including the location of the erroneous content and the correction content. An alternative method includes receiving correction information submitted by a user for erroneous content in a web page, the correction information including a location of the erroneous content and correction content; storing the received correction information; and retrieving the correction information and sending the correction information to the user in response to the user's request for visiting the web page.

Abstract: The present invention provides a CD81 and OCLN double transgenic mouse and its construction method and use. The double transgenic mouse can be used to constitute acute and chronic HCV infection in a mouse model.

Abstract: A driving system of an electric vehicle and an electric vehicle comprising the same are provided. The driving system comprises: a driving motor, a transmission and a hydraulic system. The transmission may include an input shaft, an output shaft, a first transmission unit, a first clutch, a second transmission unit and a second clutch.

Abstract: A compound of formula: where Ar1, Ar2, X, R3, and m are as disclosed herein or a pharmaceutically acceptable salt thereof (a “Cycloheteroalkenyl Compound”); compositions comprising an effective amount of a Cycloheteroalkenyl Compound; and methods for treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia, or depression in an animal comprising administering to an animal in need thereof an effective amount of a Cycloheteroalkenyl Compound are disclosed herein.

Abstract: Disclosed are a catalyst and preparation method and use thereof. The catalyst has a constitution represented as the formula below, wherein, D represents at least one element selected from the group consisting of copper, magnesium, manganese, stibium and zinc; E represents at least one element selected from the group consisting of tungsten, silicon, nickel, palladium, ferrum and plumbum; Z is selected from the group consisting of SiC, MoO3, WO3, TiO2 and ZrO2; y/x=11.1-50:100; a=0.1-3; b=0.01-5; c=0.01-5; d=0.01-3; e=0.01-2; f is the proportion of oxygen atom balancing the valence. The method comprises: (i) formulating Solution A with molybdenum, phosphorus, and vanadium compounds; formulating Solution B with dissolve potassium compound and a D-containing compound; formulating Solution C with an E-containing compound; (ii) mix Solutions A, B and C under a temperature of ?5-10° C.

Abstract: A compound of formula: where Ar1, Ar2, X, R3, and m are as disclosed herein or a pharmaceutically acceptable salt thereof (a “Cycloheteroalkenyl Compound”); compositions comprising an effective amount of a Cycloheteroalkenyl Compound; and methods for treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia, or depression in an animal comprising administering to an animal in need thereof an effective amount of a Cycloheteroalkenyl Compound are disclosed herein.

Abstract: Piperidine Compounds; compositions comprising a Piperidine Compound; and methods for treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia, or depression in an animal comprising administering to an animal in need thereof an effective amount of a Piperidine Compound are disclosed. In one embodiment, the Piperidine Compound has the formula: and pharmaceutically acceptable salts thereof, wherein Ar1, Ar2, X, R3, R4, and m are as disclosed herein.

Abstract: A seed-specific expression vector and its construction methods and applications are disclosed. A fusion protein expression cassette consisting of Arachis hypogaea oleosin gene-apolipopoprotein A-IMilano (A-IM) gene driven by Brassica napus oleosin gene promoter is inserted between the HindIII and SacI sites of a plant binary expression vector pBI121, obtaining the plant expression vector pBINOA of the invention. In addition, a method for producing apolipoprotein A-IMilano is provided, in which the expression vector is used to transform oil sunflower which is used as a plant bioreactor. The method can not only improve the yield of apolipoprotein A-IMilano, but also greatly reduce production costs, and is suitable for industrial production.

Abstract: The present invention provides a preparation process of complex oxides catalyst containing Mo, Bi, Fe and Co, which comprising steps as following: dissolving precursor compounds of the components for catalyst and complexing agent in water to obtain a solution, and then drying, molding and calcining the solution to obtain catalyst. The catalyst is used for gas phase oxidation of light alkenes to unsaturated aldehydes. The catalyst has high activity, selectivity and stability. The reaction condition is mild. The preparation process of the catalyst is easy to operate and can be used for mass production.

Abstract: The present invention provides a process for regenerating a deactivated heteropolymolybdophosphoric acid catalyst, comprising the steps of grinding the deactivated catalyst into particles having a particle size of 40 mesh or less, mixing the particles with a mixture comprising aqua ammonia, which is an aqueous solution containing ammonium ions and organic auxiliaries, kneading the mixture of particles and aqua ammonia in a kneader to obtain a paste, drying the paste, molding the paste into cylindrical particles with a through hole in its longitudinal axis, and heating the paste in atmosphere at 350˜450° C. for 1˜10 hours to produce the generated catalyst.

Abstract: A compound of formula: where Ar1, Ar2, X, R3, and m are as disclosed herein or a pharmaceutically acceptable salt thereof (a “Cycloheteroalkenyl Compound”); compositions comprising an effective amount of a Cycloheteroalkenyl Compound; and methods for treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia, or depression in an animal comprising administering to an animal in need thereof an effective amount of a Cycloheteroalkenyl Compound are disclosed herein.

Abstract: A method for producing a gift card for a gift imaging product, comprises receiving an order of the gift imaging product from a user, producing the gift imaging product, producing the gift card by the user for the gift imaging product; and consolidating the gift card with the gift imaging product into one package.

Abstract: An automated manufacturing system comprises a computer processing system and a plurality of consolidation systems. The computer processing system receives information on product subbatches and product packages and consolidation status information to produce consolidation assignment information, each product package comprising one or more product subbatches. The consolidation systems receive the product subbatches in accordance to the consolidation assignment information and consolidate the product subbatches into product packages, wherein the status of the consolidation systems are tracked and the consolidation status information is sent to the computer processing system.